Affymetrix will utilize the two technologies for pre-clinical applications, such as formalin fixed paraffin embedded (FFPE) samples, central to the study of cancer genomics. Genisphere's proprietary ...

Genomatix Software GmbH today announced that it has achieved GeneChip-compatible TM status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has ...

Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...

The widely-used Affymetrix Whole-Transcript Gene 1.0 ST (sense target) microarray platform, normally used to assay gene expression, can also be utilized to interrogate exon-specific splicing. Research ...

We offer genotyping and microarray gene expression analyses using Thermofisher (formerly known as Affymetrix) array platforms. We are one of only a handful of labs in Europe to offer high throughput ...

Affymetrix, Inc., a pioneer in microarray technology and a leader in genomics analysis, and XRGenomics LTD, a UK based biotechnology company, announced that they will collaborate on research and ...

Microarray giant Affymetrix has updated two of its more popular expression sets. With the release of the GeneChip ® Mouse Expression Set 430 and Rat Expression Set 230, the company now provides "the ...

Affymetrix Inc. announced that the US Food and Drug Administration (FDA) has granted regulatory clearance to its GCS3000Dx (GCSDx) platform for in vitro gene expression diagnostic testing. The ...

Nature uses a common framework when building organisms as different as yeast, worms, fruit flies, mice, and humans. This makes it possible for scientists to learn about how our own genes work by ...

WASHINGTON, June 4 (Reuters) - A U.S. patent appeals court ruled on Thursday in favor of Agilent Technologies , which had been involved in a patent fight with Affymetrix Inc . The dispute was over ...